Effectiveness of robust optimization in intensity‐modulated proton therapy planning for head and neck cancers

Abstract

CTV-based robust optimization provided significantly more robust dose distributions to targets and organs than PTV-based conventional optimization in H&N using IMPT. Eliminating the use of PTV and planning directly based on CTV provided better or equivalent normal tissue sparing.